Bilateral stenosis of renal arteries in a patient with primary antiphospholipid syndrome following hemolyticouremic syndrome (a case report and review of literature)


Cite item

Full Text

Full Text

Двусторонний стеноз почечных артерий у больного первичным антифосфолипидным синдромом, перенесшего гемолитико-уремический синдром (описание случая и обзор литературы). -
×

References

  1. Piette J. С., Kleinknecht D., Bach J.-F. Renal manifestation in the anti phospholipid syndrome. In: Asherson R., Cervera R., Piette J. C, Schoenfeld Y., eds. The anti phospholipid syndrome. Boca Raton: CRC Press; 1996. 169-181.
  2. Nzerue С. M., Hewan-Lowe K., Pierangeli S., Harris E. N. "Black swan in the kidne": renal involvement in the antiphos-pholipid syndrome. Kidney Int. 2002; 62: 733-744.
  3. Levine J. S., Rauch J. Renal involvement in the anti phospholipid syndrome. In: Adu D., Emery P., Madaio M., eds. Rheumatology and the kidney. Oxford: University Press; 2001. 133-166.
  4. Nochy D., Daugas E., Droz D. et al. The intrarenal vascular lesions associated with primary anti phospholipid syndrome. J. Am. Soc. Nephrol. 1999; 10: 507-518.
  5. Шилов E. M., Козловская H. Л., Метелева H. А. и др. Клинические проявления нефропатии, связанной с антифос-фолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003; 75 (6): 22-27.
  6. Moss К. Е., Isenberg D. A. Comparison of renal disease and outcome in patients with primary anti phospholipid syndrome, anti phospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. J. Rheumatol. 2001; 40: 863-867.
  7. Козловская H. Л., Шилов E. M., Метелева H. А. и др. Клинические и морфологические особенности волчаночного нефрита при системной красной волчанке с антифосфолипидным синдромом. Тер. арх. 2006; 5: 21-31.
  8. Daugas Е., Nochy D., Thi Huong D. L. et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J. Am. Soc. Nephrol. 2002; 13: 42-52.
  9. Ostuni P. A., Lazzarin P., Pengo V. et al. Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Arm. Rheum. Dis. 1990; 49: 184-187.
  10. Ryšava R., Žabka J., Peregrin J. Acute renal failure due to bilateral renal artery thrombosis associated with primary anti phospholipid syndrome. Nephrolliyal. Dial. Trasplant. 1998; 13: 2645-2647.
  11. Godfrey Т., Khamashta M. A., Hughes G. R. V. Antiphospholipid syndrome and renal artery stenosis. Quart. J. Med. 2000; 93: 127-129.
  12. Remondino G. I., Mysler E., Pissano M. N. et al. A reversible bilateral renal artery stenosis in association with anti phospholipid syndrome. Lupus 2000; 9: 65-67.
  13. Sangle S. R., D'Cruz D. P., Jan W. et al. Renal artery stenosis in the anti phospholipid (Hughes) syndrome and hypertension. Ann. Rheum. Dis. 2003; 62: 999-1002.
  14. Ben-Ami D., Bar-Meir E., Shoenfeld Y. Stenosis in antiphospholipid syndrome: a new finding with clinical implications. Lupus 2006; 15: 466-472.
  15. Rossi E., Sani C., Zini M. et al. Anticardiolipin antibodies and renovascular hypertension. Ann. Rheum. Dis. 1992; 51: 1180-1181.
  16. Cacoub P., Wechsler В., Piette J. C. et al. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis, din. Exp. Rheum. 1993; 11 (5): 479-485.
  17. Asherson R. A., Nobel С. E., Hughes G. R. V. Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome. J. Rheumatol. 1991; 18 (9): 1413-1415.
  18. Cacoub P., Piette J. C., Wechsler B. et al. Severe systemic hypertension due to renal artery lesion in systemic lupus erythematosus with antiphospholipid syndrome. Arthr. and Rheum. 1993; 36: 5186.
  19. George J., Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997; 6: 559-560.
  20. Matsuura E., Kobayashi K., Koike Т., Shoenfeld Y. Autoantibodymediated atherosclerosis. Autoimmun. Rev. 2002; 1 (6): 348-353.
  21. Berkun Y., Padeh S., Barash J. et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthr. and Rheum. 2006; 55: 850-855.
  22. Riccialdelli L., Arnaldi G., Giacchetti G. et al. Hypertension due to renal artery occlusion in a patient with antiphospholipid syndrome. Am. J. Hypertens. 2001; 14: 62-65.
  23. D'Cruz D. P. Renal manifestation of the antiphospholipid syndrome. Lupus 2005; 14: 45-48.
  24. Решетняк Т. M. Антифосфолипидный синдром: клиника, диагностика, вопросы патогенеза. Автореф. дис. ... д-ра мед. наук. М.; 1999.
  25. Welch G. N., Loscalso J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998; 338: 1042-1050.
  26. Fryer R. H., Wilson B. D., Gubler D. B. et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induced tissue factor activity in endothelial cells. Arterioscler. Thromb. 1993, 13; 1327-1333.
  27. McCully К. S. Homocysteine, folate, vitamin B6 and cardiovascular disease. J. A. M. A. 1998; 279: 392-393.
  28. Мухин H. А., Моисеев С. В., Фомин В. В. Гипергомоцистеинемия - кардиоваскулярные проблемы нефрологических больных. Кардиоваск. тер. и профилакт. 2002; 1: 85-94.
  29. Tanis В. С., Blom Н. J., Bloemenkamp D. G. et al. Folate, homocysteine level, methylentetrahydrofolate reductase (MTHFR) 677C ⇒ T variant and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels. J. Thromb. Haemost. 2004; 2: 35-41.
  30. Hassan A., Hunt B. J., О'Sullivan M. et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219.
  31. Kluijtmans L. A., Whitehead A. S. Methylentetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease. Eur. Heart J. 2001; 22: 294-299.
  32. Queffeulou G., Michel C., Vrtovsnik F. et al. Hyperhomo-cysteinemia, low folate status, homozygous C677T mutation of the methylentetrahydrofolate reductase and renal arterial thrombosis. Clin. Nephrol. 2002; 57: 158-162.
  33. Koupepidou P., Deltas C., Christofides Т. C. et al. The MTHFR 677TT and 677CT/1298 AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure. Int. Angiol. 2005; 24: 287-294.
  34. Roubey R. A. S. Mechanisms of autoantibody-mediated thrombosis. Lupus 1998; 7: S114-S119.
  35. Meroni P. L., Riboldi P. Pathogenetic mechanism mediating antiphospholipid syndrome. Curr. Opin. Rheumatol. 2001; 13: 377-382.
  36. Huang J.-J., Cheb M.-W., Sung J.-M. et al. Postpartum haemolytic uremic syndrome associated with antiphospholipid syndrome. Nephrol. Dial. Transplant. 1998; 13: 182-186.
  37. Ardiles L. G., Olavarria F., Elgueta M. et al. Anticardiolipin antibodies in classic pediatric haemolytic-uremic syndrome: a possible pathogenic role. Nephron 1998; 78: 278-283.
  38. Те Loo M., van der Velden Т., Onland W. et al. Anticardiolipin antibodies in D+ haemolytic uremic syndrome. Pediatr. Nephrol. 2002; 17: 1042-1046.
  39. Asherson R. A. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndrome ("MAPS"). Autoimmun. Rev. 2006; 6: 76-80.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies